ORPHA:98984
Pulverulent cataract
Also known as: Coppock-like cataract · Dusty cataract
Query health: suspect — Only one of 2 strategies returned hits (phrase).
Publications
201
48th percentile
Trials
0
Interventional, condition-specific
Researchers
929
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0011430
- MeSH:C565133
- UMLS:C1833118
Additional Mondo synonyms (2)
dusty cataract · pulverulent cataract
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
201 matched papers (52 in last 10 years) Source
- Phenotype characterisedNot found
No HPO disease–phenotype associations via Monarch for these Mondo IDs
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPartial
None under the specific name; 1253 for broader category cataract
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
None returned for this Mondo ID. That often means “not linked under this ID,” not “no clinical features.”
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
201
201 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
201 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
52 in the last 10 years · high confidence · 48th percentile (publications denominator)
Phrase hits: 201 · MeSH hits: 0
Who's working on it?
929
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Berry V14 papers · 2025
Department of Molecular Genetics, Institute of Ophthalmology, London, UK. vberry@hgmp.mrc.ac.uk
Papers in Europe PMC - 02Shiels A13 papers · 2024
Ophthalmology and Visual Sciences, Washington University School of Medicine, 660 S. Euclid Ave., Box 8096, St. Louis, MO, 63110, USA. shiels@wustl.edu.
Papers in Europe PMC - 03Moore AT10 papers · 2020
Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK.
Papers in Europe PMC - 04Hejtmancik JF9 papers · 2019
MOGS/OGVFB/NEI/NIH, Building 10, Bethesda, MD 20892, USA. f3h@helix.nih.gov
Papers in Europe PMC - 05
- 06Ionides A8 papers · 2025
Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK.
Papers in Europe PMC - 07Bhattacharya SS7 papers · 2009Papers in Europe PMC
- 08Graw J7 papers · 2011
Helmholtz Center Munich - German Research Center for Environmental Health, Institute of Developmental Genetics, D-85764 Neuherberg, Germany.
Papers in Europe PMC - 09Vanita V7 papers · 2024
Centre for Genetic Disorders, Guru Nanak Dev University, Amritsar, India. vanita_kumar@yahoo.com
Papers in Europe PMC - 10Mackay D6 papers · 1999
Department of Molecular Genetics, Institute of Ophthalmology, London, United Kingdom.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 1,253 trials are registered for cataract, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 26 October 2026 · last trial check 26 October 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5498 of 7126). Here are the researchers publishing on it.
high confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
1,253 interventional trials matched cataract, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: cataract
1,253
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT07260695·RECRUITING·Odyssey Evaluation in Post LASIK Patients
Conditions: Cataract·Matched via name phrase
- NCT07015034·RECRUITING·Developing and Testing a Model to Identify Preventive Vision Loss Among Older Patients in General Practice
Conditions: Vision Impairment and Blindness · Glaucoma · Age-Related Macular Degeneration · Cataract·Matched via name phrase
- NCT06950619·NOT YET RECRUITING·Associations Between Dental Anomalies and Ocular, Cutaneous and Skin Appendages Features
Conditions: Congenital Cataract · Tooth Abnormalities · Ocular Pathologies·Matched via name phrase
- NCT07325227·NOT YET RECRUITING·Study of Remimazolam for Cataract Surgery
Conditions: Cataract Surgery Anesthesia·Matched via name phrase
- NCT06865235·RECRUITING·Efficacy and Safety of Gonioscopy Assisted Transluminal Trabeculotomy in Patients with Primary Open-angle Glaucoma and Cataract.
Conditions: Open Angle Glaucoma (OAG)·Matched via name phrase
- NCT06990074·RECRUITING·An Early Feasibility, Prospective, Single-Arm Study of the Polaris System
Conditions: Cataract, Age-Related·Matched via name phrase
- NCT07713069·NOT YET RECRUITING·OCT-PRO Model vs. Clinicians: Cataract Surgery Outcome Prediction
Conditions: Cataract·Matched via name phrase
- NCT07587138·RECRUITING·Clinical Evaluation of a Novel Trifocal IOL
Conditions: Aphakia · Cataract·Matched via name phrase
- NCT07418333·NOT YET RECRUITING·Efficacy of EPD-09-25 for Eyelid Hygiene Before and After Eye Surgery.
Conditions: Cataract Surgery · Ocular Infections·Matched via name phrase
- NCT07407049·NOT YET RECRUITING·Comparison of Early Postoperative Visual Acuity Between Intracapsular and Supracapsular Phacoemulsification: A Randomized Controlled Clinical Trial
Conditions: Cataract·Matched via name phrase
- NCT07657858·RECRUITING·Effect of Dry Eye Treatment on Corneal Astigmatism Measurements
Conditions: Dry Eye · Cataract·Matched via name phrase
- NCT07790887·NOT YET RECRUITING·A Prospective, Single-Arm Clinical Evaluation of Visual, Refractive, and Patient-Reported Outcomes Following Bilateral Implantation of the TECNIS PureSee™ Extended Depth of Focus Intraocular Lens
Conditions: Cataract·Matched via name phrase
- NCT07218796·RECRUITING·Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
Conditions: Cataract · Glaucoma · Ocular Hypertension·Matched via name phrase
- NCT07484659·RECRUITING·Reducing Patient Waiting Time for Cataract Surgery
Conditions: Cataract Surgery·Matched via name phrase
- NCT05587205·RECRUITING·Safety and Tolerability of EO2002
Conditions: Cataract · Endothelial Cell Loss, Corneal·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Pulverulent cataract — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Pulverulent cataract" OR "Coppock-like cataract" OR "Dusty cataract"
MeSH descriptor terms unioned into the query: Cataract, Coppock-Like
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Pulverulent cataract" OR "Coppock-like cataract" OR "Dusty cataract" OR "Cataract, Coppock-Like"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"cataract"
Query health: suspect — strategies attempted: phrase, mesh; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T05:51:28.223Z
